Capabilities

Life Sciences Industry

The success of our life sciences clients depends not only on their scientific discoveries, but also on their ability to protect and enhance the value of those discoveries and turn them into commercial products, and navigate those products through a challenging global business and government environment. A seasoned, creative, and practical legal team is essential in this process.

Arnold & Porter Kaye Scholer is a global leader in representing life sciences clients, with a unique depth and breadth of experience. For nearly seven decades, our attorneys have successfully represented a broad spectrum of life sciences clients. In fact, we actively represent approximately 39 of the world's top 50 pharmaceutical companies listed in Pharmaceutical Executive's "2016 Pharma 50," handling the most complex and high-stakes matters for these clients. We have nearly 200 attorneys providing the full range of litigation, regulatory, intellectual property, and transactional services to pharmaceutical, biotechnology, medical device and diagnostic companies, individual scientist entrepreneurs, emerging growth companies, universities, nonprofit institutions, and investors.

We believe the years of experience we have gained from representing scores of life sciences companies sets us apart; we have been a trusted adviser to many life sciences clients for multiple decades. While some legal firms working in the sector are strong in a few practice areas, the majority of our practice groups have significant depth in life sciences. Our life sciences offerings cover regulatory matters, internal investigations, civil and criminal government investigations, domestic and global compliance programs, patent procurement, structuring and fund raising, corporate transactions, mergers and acquisitions, tax and securities offerings, licensing and other partnering transactions, patent and commercial litigation, antitrust, product liability, and government contracting.

This is not merely the convenience of "one-stop shopping" – we know that our clients want individual lawyers with great experience and that provide added value. We believe our clients choose us in part because we offer strategic value at all stages of a product's life cycle, whether in dealing with governmental agencies (in the US, Europe, or Asia), consumers, plaintiffs, commercial partners, or investors.

Our teams in the US and Europe include experienced attorneys, many of whom have previous government agency experience, as well as healthcare practitioners, scientists, and public policy specialists. These professionals work together to provide our clients with seamless, comprehensive, and sophisticated analyses, and strong and zealous advocacy.

The following shows how our practices regularly support our clients at each stage of the product life cycle:

Perspectives

A Reality Check for the Genomic Revolution
PharmaTimes
The Impact of Artificial Intelligence on Medical Innovation in the European Union and United States (pdf)
Intellectual Property & Technology Law Journal, Vol. 29, No. 8
4 Cases That Could Affect Gov't Contracts For Tech
Aerospace & Defense Law360, Appellate Law360, Government Contracts Law360, Intellectual Property Law360, Technology Law360
Disclosure of Clinical Trial Data by the EMA: Where are we now?
Clinical Trials Arena
VALUeHEALTH: A Business Plan for Sustainable eHealth Interoperability in the EU
Digital Health Download
More

Recognition

Chambers USA
Healthcare: Pharmaceutical/Medical Products Regulatory (2005-2017)
Life Sciences (Nationwide) (2007-2017)
Healthcare (DC) (2010-2017)
Chambers Global
Life Sciences (2008-2017)
U.S. News & World Report and Best Lawyers
"Best Law Firms" for FDA Law (2010-2016)
"Best Law Firms" for Healthcare Law (2010-2016)
More
Overview

Email Disclaimer